Literature DB >> 20502337

Inference for mutually exclusive competing events through a mixture of generalized gamma distributions.

William Checkley1, Roy G Brower, Alvaro Muñoz.   

Abstract

BACKGROUND: Time-to-event data with 2 or more types of endpoints are found in many epidemiologic settings. Instead of treating the times for one of the endpoints as censored observations for the other, we present an alternative approach where we treat competing events as distinct outcomes in a mixture. Our objective was to determine if and how the mixture was modified in response to an intervention.
METHODS: We used a mixture of generalized gamma distributions to concatenate the overall frequency and distribution of the times of 2 competing events commonly observed in critical care trials, namely (1) unassisted breathing followed by discharge home alive and (2) in-hospital death. We applied our proposed methods to data from 2 randomized clinical trials of critically ill patients.
RESULTS: Mechanical ventilation with lower tidal volumes modified the mixture (P = 0.103) when compared with traditional tidal volumes by lowering the overall frequency of death (P = 0.005), rather than through affecting either the distributions of times to unassisted breathing (P = 0.477) or times to death (P = 0.718). Likewise, use of a conservative versus a liberal fluid management modified the mixture (P < 0.001) by achieving earlier times to unassisted breathing (P < 0.001) and not through affecting the overall frequency of death (P = 0.202) or the distribution of times to death (P = 0.693).
CONCLUSIONS: A mixture approach to competing risks provides a means to determine the overall effect of an intervention and insights into how this intervention modifies the components of the mixture.

Entities:  

Mesh:

Year:  2010        PMID: 20502337      PMCID: PMC3227544          DOI: 10.1097/EDE.0b013e3181e090ed

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  13 in total

Review 1.  Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.

Authors:  R J Little; D B Rubin
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

2.  Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies.

Authors:  Stephen R Cole; Rui Li; Kathryn Anastos; Roger Detels; Mary Young; Joan S Chmiel; Alvaro Muñoz
Journal:  Stat Med       Date:  2004-11-15       Impact factor: 2.373

3.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

5.  Causal inference for non-mortality outcomes in the presence of death.

Authors:  Brian L Egleston; Daniel O Scharfstein; Ellen E Freeman; Sheila K West
Journal:  Biostatistics       Date:  2006-09-15       Impact factor: 5.899

6.  Principal stratification designs to estimate input data missing due to death.

Authors:  Constantine E Frangakis; Donald B Rubin; Ming-Wen An; Ellen MacKenzie
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

7.  Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution.

Authors:  Christopher Cox; Haitao Chu; Michael F Schneider; Alvaro Muñoz
Journal:  Stat Med       Date:  2007-10-15       Impact factor: 2.373

8.  A generalized F mixture model for cure rate estimation.

Authors:  Y Peng; K B Dear; J W Denham
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

9.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

10.  Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

Authors:  David A Schoenfeld; Gordon R Bernard
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

View more
  19 in total

1.  Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation.

Authors:  James H Finigan; Rangnath Mishra; Vihas T Vasu; Lori J Silveira; David E Nethery; Theodore J Standiford; Ellen L Burnham; Marc Moss; Jeffrey A Kern
Journal:  Eur Respir J       Date:  2012-05-17       Impact factor: 16.671

2.  Horizontal mixture model for competing risks: a method used in waitlisted renal transplant candidates.

Authors:  Katy Trébern-Launay; Michèle Kessler; Sahar Bayat-Makoei; Anne-Hélène Quérard; Serge Briançon; Magali Giral; Yohann Foucher
Journal:  Eur J Epidemiol       Date:  2017-10-30       Impact factor: 8.082

3.  Nonparametric Assessment of Differences Between Competing Risk Hazard Ratios: Application to Racial Differences in Pediatric Chronic Kidney Disease Progression.

Authors:  Derek K Ng; Daniel A Antiporta; Matthew B Matheson; Alvaro Muñoz
Journal:  Clin Epidemiol       Date:  2020-01-20       Impact factor: 4.790

4.  Incidence of Initial Renal Replacement Therapy Over the Course of Kidney Disease in Children.

Authors:  Derek K Ng; Matthew B Matheson; Bradley A Warady; Susan R Mendley; Susan L Furth; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

Review 5.  Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes.

Authors:  Rebecca A Pierce; Justin Lessler; Aaron M Milstone
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

6.  Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease.

Authors:  Derek K Ng; Marva Moxey-Mims; Bradley A Warady; Susan L Furth; Alvaro Muñoz
Journal:  Ann Epidemiol       Date:  2016-10-08       Impact factor: 3.797

Review 7.  Insights from the Chronic Kidney Disease in Children (CKiD) study.

Authors:  Lawrence Copelovitch; Bradley A Warady; Susan L Furth
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

8.  Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-01-03       Impact factor: 4.897

9.  Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

10.  Measuring and Analyzing Length of Stay in Critical Care Trials.

Authors:  Michael O Harhay; Sarah J Ratcliffe; Dylan S Small; Leah H Suttner; Michael J Crowther; Scott D Halpern
Journal:  Med Care       Date:  2019-09       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.